SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-09-083593
Filing Date
2009-04-21
Accepted
2009-04-21 17:20:02
Documents
9
Period of Report
2009-06-04
Effectiveness Date
2009-04-21

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 399851
2 GRAPHIC g54122g12d92.jpg GRAPHIC 36497
3 GRAPHIC g54122g24y22.jpg GRAPHIC 1347
4 GRAPHIC g54122g35h09.jpg GRAPHIC 7966
5 GRAPHIC g54122g46y86.jpg GRAPHIC 7878
6 GRAPHIC g54122g54p63.jpg GRAPHIC 1550
7 GRAPHIC g54122g60i18.jpg GRAPHIC 41076
8 GRAPHIC g54122g67y21.jpg GRAPHIC 45953
9 GRAPHIC g54122g78f71.jpg GRAPHIC 15635
  Complete submission text file 0001193125-09-083593.txt   620058
Mailing Address 501 CANAL BLVD SUITE A100 RICHMOND CA 94804
Business Address 501 CANAL BLVD SUITE A100 RICHMOND CA 94804 5109706000
SANGAMO BIOSCIENCES INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30171 | Film No.: 09762272
SIC: 2836 Biological Products, (No Diagnostic Substances)